• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Bunge Limited filed SEC Form 8-K: Other Events, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/19/25 4:02:34 PM ET
    $BG
    Packaged Foods
    Consumer Staples
    Get the next $BG alert in real time by email
    bg-20250515
    0001996862false00019968622025-05-152025-05-19

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________________
    FORM 8-K
    ___________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    May 15, 2025
    Date of Report (date of earliest event reported)
    ___________________________________
    BUNGE GLOBAL SA
    (Exact name of registrant as specified in its charter)
    ___________________________________
    Switzerland
    (State of Incorporation)
    000-56607
    (Commission File Number)
    98-1743397
    (IRS Employer Identification Number)
    Route de Florissant 13,
    1206 Geneva, Switzerland
    N.A
    (Address of registered office and principal executive office)
    (Zip Code)
    1391 Timberlake Manor Parkway
    Chesterfield, MO
     63017
    (Address of corporate headquarters )
    (Zip Code)
    (314) 292-2000
    (Registrant's telephone number, including area code)
    N/A
    (Former name or former address, if changed since last report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol
    Name of each exchange on which registered
    Registered Shares, $0.01 par value per shareBGNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    5.07 - Submission of Matters to a Vote of Security Holders
    At the 2025 Annual General Meeting of Shareholders of Bunge Global SA (the "Company") held on May 15 2025 (the "AGM"), the Company's shareholders voted on the proposals set forth below, each of which is described in the Company's proxy statement for the 2025 AGM:
    1.The shareholders approved the Swiss statutory consolidated financial statements and Swiss standalone statutory financial statements of the Company for the year ended December 31, 2024. The tabulation of votes on this matter was as follows:
    Votes ForVotes AgainstAbstentions
    100,983,42246,694335,675
    2.    The shareholders approved the appropriation of the accumulated loss for fiscal year 2024. The tabulation of votes on this matter was as follows:
    Votes ForVotes AgainstAbstentions
    101,256,67949,29959,813
    3.    The shareholders approved a cash dividend in the aggregate amount of U.S. $2.80 per outstanding share out of the Company's reserve from capital contributions in four equal installments. The tabulation of votes on this matter was as follows:
    Votes ForVotes AgainstAbstentions
    101,308,77232,57324,446
    4    The shareholders approved the discharge of the members of the Board and the Executive Management Team from liability for activities during fiscal year 2024. The tabulation of votes on this matter was as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    99,978,2961,018,116369,3796,743,664
    5.     The shareholders elected the following 8 individuals listed below as directors, each for a term extending until completion of the 2026 annual general meeting. The tabulation of votes with respect to the re-election of the directors below was as follows:
    NomineeVotes ForVotes AgainstAbstentionsBroker Non-Votes
    5a.Eliane Aleixo Lustosa de Andrade99,584,837 575,6901,205,2646,743,664
    5b.Carol M. Browner92,784,874 7,376,1891,204,7286,743,664
    5c.Gregory A. Heckman101,066,844 260,21338,7346,743,664
    5d.Linda Jojo100,007,093 149,6491,209,0496,743,664
    5e.Monica McGurk99,398,455 759,3781,207,9586,743,664
    5f.Kenneth Simril99,557,112 602,7051,205,9746,743,664
    5g.Henry (Jay) Winship97,987,268 2,169,2431,209,2806,743,664
    5h.Mark N. Zenuk97,417,623 2,738,9011,209,2676,743,664
    The shareholders elected the following 4 individuals listed below as directors, each for a term extending until completion of the 2026 annual general meeting, subject to and contingent upon the closing of the acquisition of Viterra Limited, as further described in the Company's 2025 Proxy statement. The tabulation of votes with respect to the election of the directors below was as follows:
    2


    NomineeVotes ForVotes AgainstAbstentionsBroker Non-Votes
    5i.Adrian Isman99,937,068 211,3671,217,3566,743,664
    5j.Anne Jensen99,917,645 223,8501,224,2966,743,664
    5k.Christopher Mahoney99,905,321 741,085719,3856,743,664
    5l.Markus Walt100,434,632 211,615719,5446,743,664
    6. The shareholders reelected Mark Zenuk as the Chair of the Board. The tabulation of votes with respect to the reelection of the Chair of the Board was as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    97,700,4502,450,6361,214,7056,743,664
    7.    The shareholders reelected each of the two members of the Human Resources and Compensation Committee elected two new members. The tabulation of votes with respect to the reelection of the two members of the Human Resources and Compensation Committee and election of two new members was as follows:
    NomineeVotes ForVotes AgainstAbstentionsBroker Non-Votes
    7a.Monica McGurk100,457,201361,535547,0556,743,664
    7b.Kenneth Simril98,717,1682,105,605543,0186,743,664
    7c.Markus Walt100,012,571135,1731,218,0476,743,664
    7d.Henry “Jay” Winship99,091,0551,058,7801,215,9566,743,664
    8.    The shareholders passed an advisory vote to approve the Named Executive Officers compensation under U.S. securities law requirements. The tabulation of votes with respect to this matter was as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    84,571,59615,444,8461,349,3496,743,664
    9a. The shareholders approved the maximum aggregate compensation of the Board for the period between the 2025 annual general meeting and the 2026 annual general meeting. The tabulation of votes with respect to this matter was as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    99,908,849334,1971,122,7456,743,664
    9b. The shareholders approved the maximum aggregate compensation of the Executive Management Team for the fiscal year 2026. The tabulation of votes with respect to this matter was as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    97,614,8162,123,6621,627,1136,743,664
    9c. The shareholders passed an advisory vote on the Swiss Compensation Report. The tabulation of votes with respect to this matter was as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    95,193,8564,760,1891,411,7466,743,664
    10. The shareholders passed an advisory vote on the Swiss Statutory Non-Financial Matter Report. The tabulation of votes with respect to this matter was as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    99,922,496572,340870,9556,743,664
    3


    11.     The shareholders elected the Swiss Statutory Independent Voting Representative. The tabulation of votes with respect to this matter was as follows:
    Votes ForVotes AgainstAbstentions
    100,560,19862,008743,585
    12. The shareholders approved the appointment of the independent auditor for U.S. securities law requirements and reelected the statutory auditor for Swiss law purposes. The tabulation of votes with respect to this matter was as follows:
    Votes ForVotes AgainstAbstentions
    99,860,9566,298,7881,949,711

    Item 8.01 – Other Events

    As further outlined in Item 5.07 above, the Company’s shareholders approved the appointment of Linda Jojo to the Company's Board at the AGM for a term extending until completion of the 2026 annual general meeting.

    A copy of the press release announcing Ms. Jojo's appointment to the Board is attached hereto as Exhibit 99.1 and the information contained therein is incorporated herein by reference.
    4


    Item 9.01 - Financial Statements and Exhibits
    (d):     Exhibits.

    Exhibit No.Description
    99.1
    Press Release, dated May 15, 2025
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document)


    5


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: May 19, 2025


    BUNGE GLOBAL SA
    By:
    /s/ Lisa Ware-Alexander
    Name:
    Lisa Ware-Alexander
    Title:
    Secretary

    6
    Get the next $BG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BG

    DatePrice TargetRatingAnalyst
    1/21/2025$115.00 → $95.00Overweight → Equal Weight
    Barclays
    8/1/2024$125.00 → $114.00Buy → Neutral
    Citigroup
    2/9/2024$122.00 → $105.00Hold → Buy
    HSBC Securities
    2/1/2024$108.00Buy
    Citigroup
    1/10/2024Outperform → Peer Perform
    Wolfe Research
    9/15/2023$122.00Hold
    HSBC Securities
    6/22/2023$138.00Buy
    ROTH MKM
    4/14/2023$120.00Outperform
    BMO Capital Markets
    More analyst ratings

    $BG
    SEC Filings

    See more
    • Bunge Limited filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Bunge Global SA (0001996862) (Filer)

      6/16/25 4:33:43 PM ET
      $BG
      Packaged Foods
      Consumer Staples
    • Bunge Limited filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Bunge Global SA (0001996862) (Filer)

      6/13/25 5:21:12 PM ET
      $BG
      Packaged Foods
      Consumer Staples
    • Bunge Limited filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Bunge Global SA (0001996862) (Filer)

      6/12/25 8:11:27 AM ET
      $BG
      Packaged Foods
      Consumer Staples